CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 4 Planned sale Chief Legal Officer sold 1,907 shares at $26.42 ($50,383)
- 4 Other disposition 10% owner disposed of 29,549 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale Chief Legal Officer sold 10,000 shares at an average $30.50 ($305,000)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 3,448 shares at $18.70 ($64,478)
- 8-K Event Acquisition or sale completed · Unregistered share sale · Other events
- 144 Insider Sale of Securities
- 4 Option exercise President and CSO acquired 90,900 shares (option exercise)
- 8-K Event Exit or restructuring costs · Regulation FD disclosure · Other events
- UPLOAD Other SEC-generated Letter
- 4 Planned sale Chief Legal Officer sold 388 shares at $22.85 ($8,866)
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 13 of 26 · 514 filings